Consent to the Distribution of Changed Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Acetylsalicylic acid 100 mg Tablet Reckitt & Colman Pharmaceuticals Limited, West Ryde, New South Wales, Australia Cardiprin Famciclovir 125 mg, 250 mg Tablets SmithKline Beecham Pharmaceuticals, Magpie Wood, Manor Royal, Crawley, Sussex, England Famvir Morphine sulphate 20 mg, 50 mg, 100 mg Note: Not to be marketed as substitutable for any other morphine sulphate product as if the two (2) products were bioequivalent. Capsule, sustained release Faulding Pharmaceuticals, Salisbury, South Australia, Australia Kapanol Amorolfine hydrochloride 5% in 2.5 mL, 5 mL Lacquer, nail Produits Roche SA, Fontenay sous Bois, France Loceryl Nail Lacquer Methadone hydrochloride 0.2% w/v (10 mg/5 mL) Linctus Stevens Chem Industries (NZ) Limited, Pakuranga, Auckland Methaforte Linctus Nedocromil sodium 2 mg per actuation Spray, metered dose for inhalation Fisons Plc., Holmes Chapel, Crewe, Cheshire, England and Fisons Plc., Loughborough, Leicestershire, England Tilade Diclofenac sodium 75 mg/3 mL Injection (ampoule) Ciba-Geigy AG, Stein, Switzerland Voltaren Dated this 31st day of January 1996. HUGH BABER, Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.